Neurofenix is aiming to make rehabilitation more autonomous, enjoyable and accessible to stroke victims.
Neurofenix has raised $6.9M in total funding. The most recent round was Series A. The last funding was announced in August 2022.
Neurofenix's investors include Entrepreneurs First, AlbionVC, Social Tech Trust, O2h Ventures, InHealth Ventures.
Neurofenix is headquartered in London, United Kingdom.
Neurofenix is aiming to make rehabilitation more autonomous, enjoyable and accessible to stroke victims.
Neurofenix is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurofenix — Funding & Investors." VCBacked, August 29, 2022, https://www.vcbacked.co/company/neurofenix. Accessed September 29, 2026.
VCBacked. (2022). Neurofenix — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/neurofenix
{{cite web |title=Neurofenix — Funding & Investors |url=https://www.vcbacked.co/company/neurofenix |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated